BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27127142)

  • 1. Relationship Between Hematogenous Tumor Cell Dissemination and Cellular Immunity in DCIS Patients.
    Gruber IV; Hartkopf AD; Hahn M; Taran FA; Staebler A; Wallwiener D; Brucker SY; Hanke J; Fehm T
    Anticancer Res; 2016 May; 36(5):2345-51. PubMed ID: 27127142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.
    Sänger N; Effenberger KE; Riethdorf S; Van Haasteren V; Gauwerky J; Wiegratz I; Strebhardt K; Kaufmann M; Pantel K
    Int J Cancer; 2011 Nov; 129(10):2522-6. PubMed ID: 21207426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer.
    Gruber I; Landenberger N; Staebler A; Hahn M; Wallwiener D; Fehm T
    Anticancer Res; 2013 May; 33(5):2233-8. PubMed ID: 23645781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ.
    Banys M; Hahn M; Gruber I; Krawczyk N; Wallwiener M; Hartkopf A; Taran FA; Röhm C; Kurth R; Becker S; Solomayer EF; Wallwiener D; Staebler A; Fehm T
    Breast Cancer Res Treat; 2014 Apr; 144(3):531-8. PubMed ID: 24590774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast.
    Banys M; Gruber I; Krawczyk N; Becker S; Kurth R; Wallwiener D; Jakubowska J; Hoffmann J; Rothmund R; Staebler A; Fehm T
    Breast Cancer Res Treat; 2012 Feb; 131(3):801-8. PubMed ID: 21455667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.
    Todenhöfer T; Hennenlotter J; Faber F; Wallwiener D; Schilling D; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Fehm T; Stenzl A; Schwentner C
    Prostate; 2015 May; 75(6):637-45. PubMed ID: 25586166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
    Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
    Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
    Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
    Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.
    Hartkopf AD; Taran FA; Wallwiener M; Hagenbeck C; Melcher C; Krawczyk N; Hahn M; Wallwiener D; Fehm T
    Breast Cancer Res; 2013; 15(5):R94. PubMed ID: 24099325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
    Campbell MJ; Baehner F; O'Meara T; Ojukwu E; Han B; Mukhtar R; Tandon V; Endicott M; Zhu Z; Wong J; Krings G; Au A; Gray JW; Esserman L
    Breast Cancer Res Treat; 2017 Jan; 161(1):17-28. PubMed ID: 27785654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
    Rack B; Zombirt E; Trapp E; Jückstock J; Andergassen U; Neugebauer J; Kost B; Weissenbacher T; Jeschke U; Schindlbeck C; Janni W; Alunni-Fabbroni M
    Oncology; 2016; 90(4):232-8. PubMed ID: 26937631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
    Abba MC; Gong T; Lu Y; Lee J; Zhong Y; Lacunza E; Butti M; Takata Y; Gaddis S; Shen J; Estecio MR; Sahin AA; Aldaz CM
    Cancer Res; 2015 Sep; 75(18):3980-90. PubMed ID: 26249178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score.
    Hartkopf AD; Wallwiener M; Kommoss S; Taran FA; Brucker SY
    Breast Cancer Res Treat; 2016 Feb; 156(1):91-5. PubMed ID: 26911294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
    Kasimir-Bauer S; Reiter K; Aktas B; Bittner AK; Weber S; Keller T; Kimmig R; Hoffmann O
    Sci Rep; 2016 May; 6():26355. PubMed ID: 27212060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
    Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
    Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.